Science Explorer Interactive view Map
Company · Ann Arbor · United States

Innovative BioTherapies (United States)

innbio.comROR OpenAlex
Research works
29
▼ 14% vs 2013–17
Citations
600
21.0 per fractional work
Top-10% rate
21.6%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Innovative BioTherapies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.08× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 6.84× its world share, 1 worksImmunology and Micro…Neuroscience: 2.27× its world share, 0 worksNeuroscienceEngineering: 0.68× its world share, 1 worksEngineeringHealth Professions: 0.47× its world share, 0 worksHealth ProfessionsMedicine: 2.60× its world share, 4 worksMedicineBusiness, Management and Accounting: 0.14× its world share, 0 worksBusiness, Management…Psychology: 2.42× its world share, 1 worksPsychologySocial Sciences: 0.29× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.

Which keywords describe research at Innovative BioTherapies (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Chronic Kidney Disease, Regenerative Medicine, Hemodialysis, Pluripotent Stem Cells, Extracellular Matrix, Cardiovascular Disease, Decellularization and Organ Engineering.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Chronic Kidney Disease4▲ 60×4 topics
  2. Regenerative Medicine4▲ 68×4 topics
  3. Hemodialysis4▲ 184×2 topics
  4. Pluripotent Stem Cells3▲ 167×2 topics
  5. Extracellular Matrix3▲ 42×4 topics
  6. Cardiovascular Disease3▲ 8.8×4 topics
  7. Inflammation3▲ 4.2×6 topics
  8. Decellularization3▲ 253×1 topic
  9. Organ Engineering3▲ 253×1 topic
  10. Acute Kidney Injury2▲ 176×2 topics
  11. Renal Failure2▲ 202×2 topics
  12. Quality of Life2▲ 6.2×2 topics
  13. Dialysis2▲ 174×1 topic
  14. Mortality2▲ 16×1 topic
  15. Biomarkers2▲ 9.9×3 topics
  16. Differentiation2▲ 83×2 topics
  17. Kidney Organoids2▲ 185×1 topic
  18. Nephrogenesis2▲ 185×1 topic
  19. Sepsis2▲ 39×3 topics
  20. Critical Care2▲ 26×3 topics
  21. Transcriptional Regulation2▲ 23×3 topics
  22. Contrast-Induced Nephropathy2▲ 202×1 topic
  23. Embryonic Stem Cells2▲ 71×1 topic
  24. Induced Pluripotent Stem Cells2▲ 150×1 topic
  25. Nephrotoxicity2▲ 135×1 topic
  26. Treatment1▲ 3.8×5 topics
  27. Immunity1▲ 13×3 topics
  28. Cancer1▲ 2.8×7 topics
  29. Cancer Immunotherapy1▲ 27×2 topics
  30. Global Trade1▲ 27×2 topics
  31. Heart Failure1▲ 8.9×4 topics
  32. Corporate Political Activity1▲ 119×1 topic
  33. Non-Communicable Diseases1▲ 24×1 topic
  34. Tissue Engineering1▲ 6.5×3 topics

Which research topics does Innovative BioTherapies (United States) publish most on?

By volume in 2022–2025: Tissue Engineering and Regenerative Medicine, Acute Kidney Injury Research, Dialysis and Renal Disease Management and Renal and related cancers.

Tissue Engineering and Regenerative Medicine: 1 fractional worksAcute Kidney Injury Research: 1 fractional worksDialysis and Renal Disea…1Dialysis and Renal Disease Management: 1 fractional worksRenal and related cancers1Renal and related cancers: 1 fractional worksMechanical Circulatory S…0Mechanical Circulatory Support Devices: 0 fractional worksPluripotent Stem Cells R…0Pluripotent Stem Cells Research: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksVagus Nerve Stimulation Research: 0 fractional worksPsychoanalysis, Philosophy, and Politics: 0 fractional worksChronic Kidney Disease and Diabetes: 0 fractional works
SurgeryNephrologyMolecular BiologyBiomedical Engineering3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Tissue Engineering and Regenerative Medicine Surgery 1 works
  2. 2 Acute Kidney Injury Research Nephrology 1 works
  3. 3 Dialysis and Renal Disease Management Nephrology 1 works
  4. 4 Renal and related cancers Molecular Biology 1 works
  5. 5 Mechanical Circulatory Support Devices Biomedical Engineering 0 works
  6. 6 Pluripotent Stem Cells Research Molecular Biology 0 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Vagus Nerve Stimulation Research Neurology 0 works
  9. 9 Psychoanalysis, Philosophy, and Politics Clinical Psychology 0 works
  10. 10 Chronic Kidney Disease and Diabetes Nephrology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.5%not open47.5%

World: 28% of research is openly available.

with international co-authors16.4%domestic only83.6%

World: 19% is written across borders.

How has Innovative BioTherapies (United States)'s research output changed?

Output in 2018–2022 was 14% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ann Arbor

All research institutions in Ann Arbor

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.